IDEXX Laboratories, Inc. (IDXX) EV/Assets Ratio: 13.69x
Is IDEXX Laboratories, Inc.’s EV/Assets ratio high or low?
IDEXX Laboratories, Inc.'s EV/Assets ratio of 13.69x is in line with its 5-year average of 15.18x, near the low end of its 5-year range (9.26x–26.58x).
The EV/Assets ratio for IDEXX Laboratories, Inc. (IDXX) is 13.69x as of Wednesday, June 10, 2026. It is below its 12-month average by 10.65% (15.32x).
IDXX EV/Assets Ratio Chart
IDXX Average EV/Assets Ratio Chart
IDXX Current vs Average EV/Assets Ratio Chart
IDXX EV/Assets Ratio Metrics
EV/ASSETS RATIO
13.69x
EV/ASSETS RATIO AVG TTM
15.32x
EV/ASSETS RATIO AVG 3Y
13.69x
EV/ASSETS RATIO AVG 5Y
15.18x
EV/ASSETS RATIO AVG 10Y
14.05x
EV/ASSETS RATIO AVG 15Y
11.06x
EV/ASSETS RATIO AVG 20Y
9.43x
CURRENT VS TTM AVG
-10.65%
CURRENT VS 3Y AVG
-0.01%
CURRENT VS 5Y AVG
-9.79%
CURRENT VS 10Y AVG
-2.59%
CURRENT VS 15Y AVG
+23.74%
CURRENT VS 20Y AVG
+45.24%
IDXX Competitors' EV/Assets Ratio
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IDEXX Laboratories, Inc. (IDXX) | $44.47B | 13.69x | 15.32x | 13.69x | 15.18x |
| Humana Inc. (HUM) | $43.78B | 0.96x | 0.75x | 0.88x | 1.10x |
| Agilent Technologies, Inc. (A) | $37.17B | 2.98x | 3.06x | 3.38x | 3.71x |
| Zoetis Inc. (ZTS) | $34.20B | 2.75x | 4.26x | 5.44x | 5.84x |
| Centene Corporation (CNC) | $31.94B | 0.33x | 0.25x | 0.39x | 0.51x |
| Medline Inc. (MDLN) | $30.90B | 1.04x | 1.18x | 1.18x | 1.18x |
| IQVIA Holdings Inc. (IQV) | $30.60B | 1.05x | 1.56x | 1.81x | 1.98x |
| DexCom, Inc. (DXCM) | $29.24B | 4.53x | 4.23x | 5.88x | 7.47x |
| Biogen Inc. (BIIB) | $29.00B | 1.10x | 0.95x | 1.19x | 1.43x |
| Veeva Systems Inc. (VEEV) | $26.73B | 2.78x | 4.63x | 5.33x | 6.99x |
IDEXX Laboratories, Inc. EV/Assets Ratio Formula & Definition
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
IDEXX Laboratories, Inc. EV/Assets Ratio FAQ
- What is the EV/Assets ratio for IDEXX Laboratories, Inc. (IDXX)?
- The EV/Assets ratio for IDXX stock is 13.69x.
- Is IDEXX Laboratories, Inc.'s EV/Assets ratio high or low?
- IDEXX Laboratories, Inc.'s EV/Assets ratio of 13.69x is in line with its 5-year average of 15.18x, near the low end of its 5-year range (9.26x–26.58x).
- What is the TTM average EV/Assets ratio for IDEXX Laboratories, Inc. (IDXX)?
- The TTM average EV/Assets ratio for IDXX stock is 15.32x.
- What is the 3Y average EV/Assets ratio for IDEXX Laboratories, Inc. (IDXX)?
- The 3Y average EV/Assets ratio for IDXX stock is 13.69x.
- What is the 5Y average EV/Assets ratio for IDEXX Laboratories, Inc. (IDXX)?
- The 5Y average EV/Assets ratio for IDXX stock is 15.18x.
- What is the 10Y average EV/Assets ratio for IDEXX Laboratories, Inc. (IDXX)?
- The 10Y average EV/Assets ratio for IDXX stock is 14.05x.
- What is the 15Y average EV/Assets ratio for IDEXX Laboratories, Inc. (IDXX)?
- The 15Y average EV/Assets ratio for IDXX stock is 11.06x.
- What is the 20Y average EV/Assets ratio for IDEXX Laboratories, Inc. (IDXX)?
- The 20Y average EV/Assets ratio for IDXX stock is 9.43x.
IDEXX Laboratories, Inc. EV/Assets Ratio History
| DATE | EV/ASSETS RATIO |
|---|---|
| 2026-06-10 | 13.69x |
| 2026-06-09 | 14.05x |
| 2026-06-08 | 13.63x |
| 2026-06-05 | 13.66x |
| 2026-06-04 | 13.72x |
| 2026-06-03 | 13.62x |
| 2026-06-02 | 13.39x |
| 2026-06-01 | 13.77x |
| 2026-05-29 | 13.69x |
| 2026-05-28 | 13.80x |
| 2026-05-27 | 13.39x |
| 2026-05-26 | 13.54x |
| 2026-05-22 | 13.59x |
| 2026-05-21 | 13.44x |
| 2026-05-20 | 13.45x |
| 2026-05-19 | 13.28x |
| 2026-05-18 | 13.27x |
| 2026-05-15 | 12.86x |
| 2026-05-14 | 12.96x |
| 2026-05-13 | 12.86x |
| 2026-05-12 | 12.98x |
| 2026-05-11 | 12.94x |
| 2026-05-08 | 13.61x |
| 2026-05-07 | 13.89x |
| 2026-05-06 | 14.06x |
| 2026-05-05 | 13.67x |
| 2026-05-04 | 13.83x |
| 2026-05-01 | 13.93x |
| 2026-04-30 | 13.77x |
| 2026-04-29 | 13.60x |
| 2026-04-28 | 13.95x |
| 2026-04-27 | 14.11x |
| 2026-04-24 | 13.89x |
| 2026-04-23 | 13.77x |
| 2026-04-22 | 14.19x |
| 2026-04-21 | 13.97x |
| 2026-04-20 | 14.31x |
| 2026-04-17 | 14.45x |
| 2026-04-16 | 13.99x |
| 2026-04-15 | 14.25x |
| 2026-04-14 | 14.33x |
| 2026-04-13 | 14.09x |
| 2026-04-10 | 13.82x |
| 2026-04-09 | 14.35x |
| 2026-04-08 | 14.52x |
| 2026-04-07 | 14.11x |
| 2026-04-06 | 14.17x |
| 2026-04-02 | 13.98x |
| 2026-04-01 | 13.86x |
| 2026-03-31 | 13.80x |
| 2026-03-30 | 13.68x |
| 2026-03-27 | 13.71x |
| 2026-03-26 | 14.07x |
| 2026-03-25 | 14.13x |
| 2026-03-24 | 14.00x |
| 2026-03-23 | 14.20x |
| 2026-03-20 | 14.17x |
| 2026-03-19 | 14.23x |
| 2026-03-18 | 14.16x |
| 2026-03-17 | 14.40x |
| 2026-03-16 | 14.39x |
| 2026-03-13 | 14.08x |
| 2026-03-12 | 14.02x |
| 2026-03-11 | 14.73x |
| 2026-03-10 | 14.69x |
| 2026-03-09 | 14.97x |
| 2026-03-06 | 14.92x |
| 2026-03-05 | 15.17x |
| 2026-03-04 | 15.89x |
| 2026-03-03 | 15.57x |
| 2026-03-02 | 15.60x |
| 2026-02-27 | 16.08x |
| 2026-02-26 | 16.18x |
| 2026-02-25 | 16.10x |
| 2026-02-24 | 15.90x |
| 2026-02-23 | 15.27x |
| 2026-02-20 | 15.57x |
| 2026-02-19 | 15.29x |
| 2026-02-18 | 15.39x |
| 2026-02-17 | 15.18x |
| 2026-02-13 | 15.26x |
| 2026-02-12 | 14.97x |
| 2026-02-11 | 15.72x |
| 2026-02-10 | 15.67x |
| 2026-02-09 | 15.51x |
| 2026-02-06 | 15.62x |
| 2026-02-05 | 15.60x |
| 2026-02-04 | 15.58x |
| 2026-02-03 | 15.34x |
| 2026-02-02 | 15.50x |
| 2026-01-30 | 16.24x |
| 2026-01-29 | 16.39x |
| 2026-01-28 | 16.65x |
| 2026-01-27 | 16.82x |
| 2026-01-26 | 16.89x |
| 2026-01-23 | 16.80x |
| 2026-01-22 | 16.73x |
| 2026-01-21 | 16.86x |
| 2026-01-20 | 16.61x |
| 2026-01-16 | 17.31x |
| 2026-01-15 | 17.23x |
| 2026-01-14 | 17.19x |
| 2026-01-13 | 17.28x |
| 2026-01-12 | 17.53x |
| 2026-01-09 | 17.26x |
| 2026-01-08 | 17.24x |
| 2026-01-07 | 17.29x |
| 2026-01-06 | 17.10x |
| 2026-01-05 | 16.52x |
| 2026-01-02 | 16.23x |
| 2025-12-31 | 16.38x |
| 2025-12-30 | 16.52x |
| 2025-12-29 | 16.65x |
| 2025-12-26 | 16.67x |
| 2025-12-24 | 16.66x |
| 2025-12-23 | 16.52x |
| 2025-12-22 | 16.99x |
| 2025-12-19 | 16.95x |
| 2025-12-18 | 16.87x |
| 2025-12-17 | 16.84x |
| 2025-12-16 | 16.78x |
| 2025-12-15 | 16.95x |
| 2025-12-12 | 17.04x |
| 2025-12-11 | 17.12x |
| 2025-12-10 | 16.99x |
| 2025-12-09 | 16.92x |
| 2025-12-08 | 17.10x |
| 2025-12-05 | 17.28x |
| 2025-12-04 | 17.36x |
| 2025-12-03 | 17.56x |
| 2025-12-02 | 17.72x |
| 2025-12-01 | 17.63x |
| 2025-11-28 | 18.20x |
| 2025-11-26 | 18.27x |
| 2025-11-25 | 18.53x |
| 2025-11-24 | 18.18x |
| 2025-11-21 | 17.56x |
| 2025-11-20 | 16.69x |
| 2025-11-19 | 16.87x |
| 2025-11-18 | 16.23x |
| 2025-11-17 | 16.20x |
| 2025-11-14 | 16.70x |
| 2025-11-13 | 16.98x |
| 2025-11-12 | 17.26x |
| 2025-11-11 | 17.24x |
| 2025-11-10 | 17.17x |
| 2025-11-07 | 17.14x |
| 2025-11-06 | 17.27x |
| 2025-11-05 | 17.42x |
| 2025-11-04 | 17.47x |
| 2025-11-03 | 17.49x |
| 2025-10-31 | 15.63x |
| 2025-10-30 | 15.61x |
| 2025-10-29 | 15.58x |
| 2025-10-28 | 15.75x |
| 2025-10-27 | 16.06x |
| 2025-10-24 | 15.91x |
| 2025-10-23 | 15.85x |
| 2025-10-22 | 15.73x |
| 2025-10-21 | 15.81x |
| 2025-10-20 | 15.97x |
| 2025-10-17 | 15.77x |
| 2025-10-16 | 15.82x |
| 2025-10-15 | 15.86x |
| 2025-10-14 | 15.81x |
| 2025-10-13 | 15.72x |
| 2025-10-10 | 15.30x |
| 2025-10-09 | 15.61x |
| 2025-10-08 | 15.64x |
| 2025-10-07 | 15.58x |
| 2025-10-06 | 15.59x |
| 2025-10-03 | 15.67x |
| 2025-10-02 | 15.73x |
| 2025-10-01 | 15.40x |
| 2025-09-30 | 15.86x |
| 2025-09-29 | 15.66x |
| 2025-09-26 | 15.70x |
| 2025-09-25 | 15.35x |
| 2025-09-24 | 15.57x |
| 2025-09-23 | 16.09x |
| 2025-09-22 | 15.98x |
| 2025-09-19 | 16.28x |
| 2025-09-18 | 16.26x |
| 2025-09-17 | 15.91x |
| 2025-09-16 | 16.02x |
| 2025-09-15 | 15.98x |
| 2025-09-12 | 15.91x |
| 2025-09-11 | 16.01x |
| 2025-09-10 | 15.83x |
| 2025-09-09 | 16.26x |
| 2025-09-08 | 16.20x |
| 2025-09-05 | 15.96x |
| 2025-09-04 | 15.90x |
| 2025-09-03 | 15.74x |
| 2025-09-02 | 15.87x |
| 2025-08-29 | 16.06x |
| 2025-08-28 | 16.06x |
| 2025-08-27 | 15.91x |
| 2025-08-26 | 15.93x |
| 2025-08-25 | 15.92x |
| 2025-08-22 | 16.02x |
| 2025-08-21 | 15.72x |
| 2025-08-20 | 15.88x |
| 2025-08-19 | 15.80x |
| 2025-08-18 | 15.83x |
| 2025-08-15 | 16.15x |
| 2025-08-14 | 16.22x |
| 2025-08-13 | 16.47x |
| 2025-08-12 | 16.18x |
| 2025-08-11 | 16.18x |
| 2025-08-08 | 16.32x |
| 2025-08-07 | 16.13x |
| 2025-08-06 | 15.50x |
| 2025-08-05 | 15.93x |
| 2025-08-04 | 16.93x |
| 2025-08-01 | 13.93x |
| 2025-07-31 | 13.90x |
| 2025-07-30 | 14.86x |
| 2025-07-29 | 14.89x |
| 2025-07-28 | 14.72x |
| 2025-07-25 | 14.69x |
| 2025-07-24 | 14.30x |
| 2025-07-23 | 14.06x |
| 2025-07-22 | 13.84x |
| 2025-07-21 | 13.56x |
| 2025-07-18 | 13.40x |
| 2025-07-17 | 13.50x |
| 2025-07-16 | 13.55x |
| 2025-07-15 | 13.70x |
| 2025-07-14 | 13.83x |
| 2025-07-11 | 13.88x |
| 2025-07-10 | 14.07x |
| 2025-07-09 | 14.06x |
| 2025-07-08 | 14.01x |
| 2025-07-07 | 14.19x |
| 2025-07-03 | 14.22x |
| 2025-07-02 | 14.11x |
| 2025-07-01 | 14.11x |
| 2025-06-30 | 13.95x |
| 2025-06-27 | 13.82x |
| 2025-06-26 | 13.73x |
| 2025-06-25 | 13.80x |
| 2025-06-24 | 13.80x |
| 2025-06-23 | 13.65x |
| 2025-06-20 | 13.63x |
| 2025-06-18 | 13.53x |
| 2025-06-17 | 13.55x |
| 2025-06-16 | 13.76x |
| 2025-06-13 | 13.60x |
| 2025-06-12 | 13.71x |
| 2025-06-11 | 13.64x |
| 2025-06-10 | 13.69x |
| 2025-06-09 | 13.50x |
| 2025-06-06 | 13.66x |
| 2025-06-05 | 13.59x |
| 2025-06-04 | 13.66x |
| 2025-06-03 | 13.68x |
| 2025-06-02 | 13.40x |
| 2025-05-30 | 13.36x |
| 2025-05-29 | 13.42x |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Jonathan J. Mazelsky